ENDRA Life Sciences Inc. (NDRA) Financial Statements (2024 and earlier)

Company Profile

Business Address 3600 GREEN COURT
ANN ARBOR, MI 48105
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  4,819,4592,355,2514,889,0988,016,35011,278,041
Cash and cash equivalents  4,819,4592,355,2514,889,0988,016,35011,278,041
Inventory, net of allowances, customer advances and progress billings2,757,6332,757,6332,735,3492,644,7172,634,0772,374,728
Inventory2,757,6332,757,6332,735,3492,644,7172,634,0772,374,728
Prepaid expense305,885506,914428,529992,875914,261834,863
Other undisclosed current assets3,334,536     
Total current assets:6,398,0548,084,0065,519,1298,526,69011,564,68814,487,632
Noncurrent Assets
Operating lease, right-of-use asset393,451431,842469,290505,816541,456576,255
Property, plant and equipment160,816192,874228,139235,655230,612239,544
Prepaid expense644,610530,068    
Other noncurrent assets    5,986 5,986
Other undisclosed noncurrent assets5,9865,986438,330 5,986 
Total noncurrent assets:1,204,8631,160,7701,135,759747,457778,054821,785
TOTAL ASSETS:7,602,9179,244,7766,654,8889,274,14712,342,74215,309,417
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,972,3621,841,5621,645,7491,523,0121,558,0971,360,365
Accounts payable419,144414,935524,027613,961636,695785,071
Accrued liabilities273,007202,226216,42660,638  
Other undisclosed accounts payable and accrued liabilities1,280,2111,224,401905,296848,413921,402575,294
Debt28,48428,484    
Other undisclosed current liabilities168,610163,013186,038180,712147,057142,025
Total current liabilities:2,169,4562,033,0591,831,7871,703,7241,705,1541,502,390
Noncurrent Liabilities
Long-term debt and lease obligation     434,257 
Long-term debt, excluding current maturities     28,484 
Liabilities, other than long-term debt237,163281,154324,064365,919  
Operating lease, liability237,163281,154324,064365,919405,773 
Other undisclosed noncurrent liabilities     (405,773)472,652
Total noncurrent liabilities:237,163281,154324,064365,919434,257472,652
Total liabilities:2,406,6192,314,2132,155,8512,069,6432,139,4111,975,042
Equity
Equity, attributable to parent, including:5,196,2986,930,5634,499,0377,204,50410,203,33113,334,375
Preferred stock   1   
Common stock8417483173176,3156,315
Additional paid in capital95,664,01194,297,16789,307,67589,068,01588,768,83188,462,324
Accumulated deficit(90,470,616)(87,369,780)(84,812,648)(81,869,902)(78,580,306)(75,140,079)
Other undisclosed equity, attributable to parent2,0622,4283,6926,0748,4915,815
Total equity:5,196,2986,930,5634,499,0377,204,50410,203,33113,334,375
TOTAL LIABILITIES AND EQUITY:7,602,9179,244,7766,654,8889,274,14712,342,74215,309,417

Income Statement (P&L) (USD)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Operating expenses(3,129,062)(2,994,565)(2,939,328)(3,313,381)(3,417,216)(3,571,693)
Operating loss:(3,129,062)(2,994,565)(2,939,328)(3,313,381)(3,417,216)(3,571,693)
Nonoperating income (expense)28,226437,433(3,418)23,785(23,011)(19,374)
Other nonoperating income (expense)28,226     
Loss from continuing operations:(3,100,836)(2,557,132)(2,942,746)(3,289,596)(3,440,227)(3,591,067)
Loss before gain (loss) on sale of properties:(3,440,227)(3,591,067)
Other undisclosed net income    26,358,184  
Net income (loss):(3,100,836)(2,557,132)(2,942,746)23,068,588(3,440,227)(3,591,067)
Other undisclosed net loss attributable to parent    (26,358,184)  
Net loss available to common stockholders, diluted:(3,100,836)(2,557,132)(2,942,746)(3,289,596)(3,440,227)(3,591,067)

Comprehensive Income (USD)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net income (loss):(3,100,836)(2,557,132)(2,942,746)23,068,588(3,440,227)(3,591,067)
Comprehensive income (loss), net of tax, attributable to parent:(3,100,836)(2,557,132)(2,942,746)23,068,588(3,440,227)(3,591,067)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: